Filing Details
- Accession Number:
- 0001209191-19-036950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-13 19:33:01
- Reporting Period:
- 2019-06-11
- Accepted Time:
- 2019-06-13 19:33:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-11 | 4,563 | $31.12 | 238,042 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-06-11 | 20,437 | $30.84 | 258,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-06-11 | 21,298 | $51.27 | 237,181 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-06-11 | 3,702 | $52.33 | 233,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-06-12 | 15,113 | $30.84 | 248,592 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-06-12 | 9,887 | $31.12 | 258,479 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-06-12 | 25,000 | $51.34 | 233,479 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-06-11 | 20,437 | $0.00 | 20,437 | $30.84 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-06-11 | 4,563 | $0.00 | 4,563 | $31.12 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-06-12 | 15,113 | $0.00 | 15,113 | $30.84 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-06-12 | 9,887 | $0.00 | 9,887 | $31.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,113 | 2024-01-28 | No | 4 | M | Direct | |
45,437 | 2025-02-13 | No | 4 | M | Direct | |
0 | 2024-01-28 | No | 4 | M | Direct | |
35,550 | 2025-02-13 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2019.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $50.90 to $51.88.
- Represents weighted average sale price. Actual sale prices ranged from $51.95 to $52.81.
- Represents weighted average sale price. Actual sale prices ranged from $50.77 to $51.61.
- The option became exercisable as to 25% of the shares on January 28, 2015, and becomes exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter.